← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. ARDX
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

ARDX logoArdelyx, Inc. (ARDX) P/E Ratio History

Historical price-to-earnings valuation from 2015 to 2015

Current P/E
-26.8
Undervalued
5Y Avg P/E
166.9
-116% vs avg
PE Percentile
0%
Low
PEG Ratio
N/A
N/A
TTM EPS$-0.24
Price$6.98
5Y PE Range166.9 - 166.9
Earnings YieldN/A

Loading P/E history...

ARDX Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
-26.8vs166.9
-116%
Cheap vs History
vs. Healthcare
-26.8vs22.3
-220%
Below Sector
vs. S&P 500
-26.8vs25.1
-207%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -53% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Ardelyx, Inc. (ARDX) trades at a price-to-earnings ratio of -26.8x, with a stock price of $6.98 and trailing twelve-month earnings per share of $-0.24.

The current P/E is 116% below its 5-year average of 166.9x. Over the past five years, ARDX's P/E has ranged from a low of 166.9x to a high of 166.9x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, ARDX trades at a 220% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, ARDX trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ARDX DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ARDX P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
CHRS logoCHRSCoherus Oncology, Inc.
$213M1.2Lowest-+472%
INVA logoINVAInnoviva, Inc.
$2B6.90.67Best+817%Best
AMGN logoAMGNAmgen Inc.
$178B23.17.86+88%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

ARDX Historical P/E Data (2015–2015)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2015 Q2$3.99$0.02166.9x+0%

Average P/E for displayed period: 166.9x

See ARDX's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ARDX Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ARDX vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

ARDX — Frequently Asked Questions

Quick answers to the most common questions about buying ARDX stock.

Is ARDX stock overvalued or undervalued?

ARDX trades at -26.8x P/E, below its 5-year average of 166.9x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.

How does ARDX's valuation compare to peers?

Ardelyx, Inc. P/E of -26.8x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.

What is ARDX's PEG ratio?

ARDX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2015-2015.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ARDX P/E Ratio History (2015–2015)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.